AtriCure (ATRC) News Today $31.62 -0.71 (-2.20%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$31.64 +0.02 (+0.08%) As of 06/13/2025 04:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ATRC Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Harbor Capital Advisors Inc. Invests $916,000 in AtriCure, Inc. (NASDAQ:ATRC)Harbor Capital Advisors Inc. bought a new position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the first quarter, according to the company in its most recent filing with the SEC. The fund bought 28,388 shares of the medical device company's stock, valued at approximately $916,000. Harbor CapitJune 14 at 3:56 AM | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Receives $50.67 Consensus Price Target from AnalystsJune 11, 2025 | americanbankingnews.comAtriCure, Inc. (NASDAQ:ATRC) Receives Average Recommendation of "Buy" from BrokeragesShares of AtriCure, Inc. (NASDAQ:ATRC - Get Free Report) have earned a consensus recommendation of "Buy" from the nine ratings firms that are currently covering the company, Marketbeat Ratings reports. Nine research analysts have rated the stock with a buy rating. The average twelve-month target pJune 8, 2025 | marketbeat.comAmeriprise Financial Inc. Invests $295,000 in AtriCure, Inc. (NASDAQ:ATRC)Ameriprise Financial Inc. bought a new position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 9,638 shares of the medical device company's sJune 6, 2025 | marketbeat.comMackenzie Financial Corp Takes Position in AtriCure, Inc. (NASDAQ:ATRC)Mackenzie Financial Corp acquired a new position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 15,214 shares of the medical device company's stock, valued at approximaJune 4, 2025 | marketbeat.comWellington Management Group LLP Lowers Stock Position in AtriCure, Inc. (NASDAQ:ATRC)Wellington Management Group LLP lessened its holdings in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 57.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 654,504 shares of the medical device company's sJune 1, 2025 | marketbeat.comAtriCure (NASDAQ:ATRC) Downgraded to "Hold" Rating by Wall Street ZenWall Street Zen downgraded AtriCure from a "buy" rating to a "hold" rating in a research note on Sunday.June 1, 2025 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Jane Street Group LLCJane Street Group LLC cut its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 40.6% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 13,300 shares of the medical device company's stock afterJune 1, 2025 | marketbeat.comInsider Sell: Vinayak Doraiswamy Sells 2,500 Shares of AtriCure Inc (ATRC)May 31, 2025 | gurufocus.comAtriCure, Inc. (NASDAQ:ATRC) Insider Vinayak Doraiswamy Sells 2,500 SharesAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) insider Vinayak Doraiswamy sold 2,500 shares of the firm's stock in a transaction dated Wednesday, May 28th. The stock was sold at an average price of $33.44, for a total transaction of $83,600.00. Following the completion of the sale, the insider now owns 73,550 shares of the company's stock, valued at $2,459,512. This trade represents a 3.29% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.May 31, 2025 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Squarepoint Ops LLCSquarepoint Ops LLC cut its holdings in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 64.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,472 shares of the medical deviceMay 31, 2025 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased its position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 20.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 811,370 shaMay 29, 2025 | marketbeat.comVoloridge Investment Management LLC Sells 129,258 Shares of AtriCure, Inc. (NASDAQ:ATRC)Voloridge Investment Management LLC cut its position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 33.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 260,412 shares of the medical device company's stock after selliMay 27, 2025 | marketbeat.comMan Group plc Purchases Shares of 24,368 AtriCure, Inc. (NASDAQ:ATRC)Man Group plc purchased a new stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 24,368 shares of the medical device company's stock, valued at approximately $745,000. A numberMay 27, 2025 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Deutsche Bank AGDeutsche Bank AG lessened its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 69.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 45,459 shares of the medical deMay 26, 2025 | marketbeat.comAtriCure (NASDAQ:ATRC) Upgraded by Wall Street Zen to "Buy" RatingWall Street Zen raised AtriCure from a "hold" rating to a "buy" rating in a research note on Saturday.May 26, 2025 | marketbeat.comATRC Crosses Below Key Moving Average LevelMay 25, 2025 | nasdaq.comTwo Sigma Investments LP Sells 106,788 Shares of AtriCure, Inc. (NASDAQ:ATRC)Two Sigma Investments LP lowered its holdings in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 14.9% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 610,996 shares of the medical device company's stock after sellingMay 25, 2025 | marketbeat.comBank of America Corp DE Sells 208,694 Shares of AtriCure, Inc. (NASDAQ:ATRC)Bank of America Corp DE reduced its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 34.8% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 390,816 shares of the medical device company's stock after selling 208,694 shares durMay 25, 2025 | marketbeat.comTwo Sigma Advisers LP Has $19.54 Million Stock Position in AtriCure, Inc. (NASDAQ:ATRC)Two Sigma Advisers LP lowered its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 3.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 639,400 shares of the medical device company's stock afMay 24, 2025 | marketbeat.comNuveen Asset Management LLC Sells 149,584 Shares of AtriCure, Inc. (NASDAQ:ATRC)Nuveen Asset Management LLC trimmed its stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 12.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,037,348 shares of the medical device company's stock afteMay 24, 2025 | marketbeat.comAtriCure to Participate in the Goldman Sachs 46th Annual Global Healthcare ConferenceMay 23, 2025 | businesswire.comFocus Partners Wealth Acquires Shares of 16,306 AtriCure, Inc. (NASDAQ:ATRC)Focus Partners Wealth acquired a new stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 16,306 shares of the medical device company's stock, valued atMay 23, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Sells 49,834 Shares of AtriCure, Inc. (NASDAQ:ATRC)D. E. Shaw & Co. Inc. reduced its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 42.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 67,462 shares of the medical device company's stock after sellinMay 23, 2025 | marketbeat.comSherbrooke Park Advisers LLC Invests $330,000 in AtriCure, Inc. (NASDAQ:ATRC)Sherbrooke Park Advisers LLC purchased a new position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 10,792 shares of the medical device company's stocMay 21, 2025 | marketbeat.comBNP Paribas Financial Markets Purchases 84,776 Shares of AtriCure, Inc. (NASDAQ:ATRC)BNP Paribas Financial Markets lifted its position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 676.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 97,310 shares of the medical device company'sMay 18, 2025 | marketbeat.comNorthern Trust Corp Has $14.78 Million Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC)Northern Trust Corp lifted its stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 11.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 483,607 shares of the medical device company's stock after acquMay 18, 2025 | marketbeat.comLMR Partners LLP Invests $499,000 in AtriCure, Inc. (NASDAQ:ATRC)LMR Partners LLP acquired a new stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 16,313 shares of the medical device company's stock, valued aMay 17, 2025 | marketbeat.comGraham Capital Management L.P. Purchases Shares of 21,249 AtriCure, Inc. (NASDAQ:ATRC)Graham Capital Management L.P. purchased a new position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm purchased 21,249 shares of the medical device company's stock, valued at approximately $649,000. SeveralMay 17, 2025 | marketbeat.comBalyasny Asset Management L.P. Decreases Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC)Balyasny Asset Management L.P. decreased its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 50.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 76,190 shares of the medical device compaMay 15, 2025 | marketbeat.comCentiva Capital LP Takes Position in AtriCure, Inc. (NASDAQ:ATRC)Centiva Capital LP purchased a new position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 16,687 shares of the medical device company's stock, valued at appMay 12, 2025 | marketbeat.comAlgert Global LLC Has $2.94 Million Stock Position in AtriCure, Inc. (NASDAQ:ATRC)Algert Global LLC raised its stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 10.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 96,199 shares of the medical device company's stock after acquiring anMay 10, 2025 | marketbeat.comDimensional Fund Advisors LP Purchases 136,015 Shares of AtriCure, Inc. (NASDAQ:ATRC)Dimensional Fund Advisors LP lifted its position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 24.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 700,212 shares of the medical device company'sMay 10, 2025 | marketbeat.comAtriCure Q1 2025 presentation: Revenue up 13.6%, raises full-year guidanceMay 9, 2025 | investing.comAtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Divisadero Street Capital Management LPDivisadero Street Capital Management LP reduced its position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 83.6% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 212,982 shares of the medical device company'sMay 9, 2025 | marketbeat.comAquatic Capital Management LLC Sells 15,898 Shares of AtriCure, Inc. (NASDAQ:ATRC)Aquatic Capital Management LLC cut its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 40.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 23,102 shares of the medical device company's stock after selling 15,898 shares duMay 4, 2025 | marketbeat.comPDT Partners LLC Acquires 15,626 Shares of AtriCure, Inc. (NASDAQ:ATRC)PDT Partners LLC raised its holdings in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 65.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 39,327 shares of the medical device company's stock after buyMay 3, 2025 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Stake Trimmed by Barclays PLCBarclays PLC lessened its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 33.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 86,541 shares of the medical device company's stock after selling 4May 3, 2025 | marketbeat.comAtriCure (ATRC) Shares Cross Below 200 DMAMay 2, 2025 | nasdaq.comUBS Group Issues Pessimistic Forecast for AtriCure (NASDAQ:ATRC) Stock PriceUBS Group dropped their price objective on AtriCure from $60.00 to $58.00 and set a "buy" rating on the stock in a research report on Wednesday.May 2, 2025 | marketbeat.comAtriCure (NASDAQ:ATRC) Given Market Outperform Rating at JMP SecuritiesJMP Securities reaffirmed a "market outperform" rating and issued a $60.00 price target on shares of AtriCure in a report on Wednesday.May 2, 2025 | marketbeat.comAtriCure (NASDAQ:ATRC) Shares Gap Down on Analyst DowngradeAtriCure (NASDAQ:ATRC) Shares Gap Down on Analyst DowngradeMay 2, 2025 | marketbeat.comAtriCure (NASDAQ:ATRC) Price Target Lowered to $44.00 at Needham & Company LLCNeedham & Company LLC reduced their price objective on shares of AtriCure from $51.00 to $44.00 and set a "buy" rating for the company in a research report on Wednesday.May 2, 2025 | marketbeat.comEmerald Mutual Fund Advisers Trust Sells 230,096 Shares of AtriCure, Inc. (NASDAQ:ATRC)Emerald Mutual Fund Advisers Trust reduced its position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 92.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 19,408 shares of the medical devicMay 2, 2025 | marketbeat.comSusquehanna Fundamental Investments LLC Invests $3.18 Million in AtriCure, Inc. (NASDAQ:ATRC)Susquehanna Fundamental Investments LLC acquired a new stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 104,094 shares of the medical device compMay 2, 2025 | marketbeat.comNebula Research & Development LLC Sells 9,703 Shares of AtriCure, Inc. (NASDAQ:ATRC)Nebula Research & Development LLC decreased its holdings in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 35.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 17,363 shares of the medical device compMay 2, 2025 | marketbeat.comAtriCure (NASDAQ:ATRC) Stock Price Up 4.9% Following Earnings BeatAtriCure (NASDAQ:ATRC) Trading 4.9% Higher After Earnings BeatMay 1, 2025 | marketbeat.comAtriCure (NASDAQ:ATRC) Issues Quarterly Earnings ResultsAtriCure (NASDAQ:ATRC - Get Free Report) announced its quarterly earnings data on Tuesday. The medical device company reported ($0.14) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.25) by $0.11. AtriCure had a negative net margin of 9.61% and a negative return on equity of 6.80%.May 1, 2025 | marketbeat.comShareholders in AtriCure (NASDAQ:ATRC) have lost 40%, as stock drops 11% this past weekMay 1, 2025 | finance.yahoo.comAdage Capital Partners GP L.L.C. Makes New $9.17 Million Investment in AtriCure, Inc. (NASDAQ:ATRC)Adage Capital Partners GP L.L.C. bought a new position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 300,000 shares of the medical device company's stock, valMay 1, 2025 | marketbeat.com Get AtriCure News Delivered to You Automatically Sign up to receive the latest news and ratings for ATRC and its competitors with MarketBeat's FREE daily newsletter. Email Address ATRC Media Mentions By Week ATRC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATRC News Sentiment▼1.160.90▲Average Medical News Sentiment ATRC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATRC Articles This Week▼35▲ATRC Articles Average Week Get AtriCure News Delivered to You Automatically Sign up to receive the latest news and ratings for ATRC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TFX News Today ITGR News Today ATEC News Today IART News Today ANGO News Today OFIX News Today SRDX News Today ARAY News Today RMTI News Today RSLS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATRC) was last updated on 6/16/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBillionaires are piling into this gold investmentBillionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AtriCure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AtriCure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ATRC Stock Free ATRC Stock Alerts